Literature DB >> 17075246

Roles of IL-18 in basophils and mast cells.

Tomohiro Yoshimoto1, Kenji Nakanishi.   

Abstract

Basophils and mast cells are effecter cells in allergen/IgE-mediated immune responses. They induce type 1 immediate immune response in airway or other organ, resulting in bronchial asthma and other allergic diseases. However, they also play a critical role in host defense against infection with helminthes. Upon linkage of FcepsilonRI with a complex of allergen and IgE, basophils and mast cells release a large amount of Th2 cytokines and chemical mediators. Therefore these responses are "acquired allergic responses" and induce allergic diseases, such as bronchial asthma. However, basophils and mast cells derived from cultured bone marrow cells with IL-3 for 10 days express IL-18Ralpha chain and produce Th2 cytokines in response to the stimulation with IL-3 and IL-18 without FcepsilonRI cross-linkage. Furthermore, they produce Th2 cytokines upon stimulation with several TLR ligands, such as LPS. This finding may suggest the presence of allergen/IgE-independent allergic responses, which we would like to designate as "innate allergic response". However, in vivo treatment with IL-18 and IL-2 protects against gastrointestinal nematode infection by activating intestinal mucosal mast cells in STAT6-independent manner, suggesting the importance of innate allergic response against helminth infection. Here we discuss the functional role of IL-18-induced "innate allergic response" in disease and host defense.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075246     DOI: 10.2332/allergolint.55.105

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  24 in total

Review 1.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

Review 3.  Basophils and type 2 immunity.

Authors:  Booki Min; William E Paul
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

Review 4.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

Review 5.  Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.

Authors:  Vera Paschon; Silvia Honda Takada; Juliane Midori Ikebara; Erica Sousa; Reza Raeisossadati; Henning Ulrich; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

Review 6.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

7.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

Authors:  Tatjana Pecaric-Petkovic; Svetlana A Didichenko; Sacha Kaempfer; Nicole Spiegl; Clemens A Dahinden
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

Review 8.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

Review 9.  Toll-like receptors in neurodegeneration.

Authors:  Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Journal:  Brain Res Rev       Date:  2008-09-12

10.  Screening of Toll-like receptors expression in multiple system atrophy brains.

Authors:  Tomasz Brudek; Kristian Winge; Tina Klitmøller Agander; Bente Pakkenberg
Journal:  Neurochem Res       Date:  2013-03-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.